Andean Precious Metals Corp. (CVE:APM – Get Free Report) Senior Officer Juan Carlos Sandoval Amare bought 31,300 shares of the stock in a transaction dated Friday, January 3rd. The shares were purchased at an average cost of C$1.21 per share, for a total transaction of C$37,860.48.
Andean Precious Metals Price Performance
APM opened at C$1.29 on Thursday. Andean Precious Metals Corp. has a fifty-two week low of C$0.57 and a fifty-two week high of C$2.18. The firm has a market capitalization of C$192.67 million, a PE ratio of 3.39 and a beta of 1.22. The company’s 50-day moving average is C$1.33 and its 200 day moving average is C$1.26.
Wall Street Analyst Weigh In
Separately, Desjardins raised shares of Andean Precious Metals to a “moderate buy” rating in a research report on Thursday, October 31st.
About Andean Precious Metals
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
Recommended Stories
- Five stocks we like better than Andean Precious Metals
- Expert Stock Trading Psychology Tips
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Ride Out The Recession With These Dividend Kings
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What is the Euro STOXX 50 Index?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.